Biovet JSC (LTS:0III) Other Long-Term Liabilities: лв4.10 Mil (As of Dec. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biovet JSC Other Long-Term Liabilities?

Biovet JSC LTS:0III Other Long-Term Liabilities is лв4.10 Mil as of Dec. 2016. The stock has 1 warning sign investors should review.

Biovet JSC's other long-term liabilities for the quarter that ended in Dec. 2016 was лв4.10 Mil.

Biovet JSC's quarterly other long-term liabilities declined from Jun. 2016 (лв3.70 Mil) to Sep. 2016 (лв3.70 Mil) but then increased from Sep. 2016 (лв3.70 Mil) to Dec. 2016 (лв4.10 Mil).

Biovet JSC's annual other long-term liabilities increased from Dec. 2014 (лв3.16 Mil) to Dec. 2015 (лв3.73 Mil) and increased from Dec. 2015 (лв3.73 Mil) to Dec. 2016 (лв4.10 Mil).

Biovet JSC Other Long-Term Liabilities Related Terms

Biovet JSC Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Biovet JSC's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC Other Long-Term Liabilities Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Other Long-Term Liabilities
Get a 7-Day Free Trial 3.11 3.21 3.16 3.73 4.10

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.73 3.73 3.70 3.70 4.10

Biovet JSC Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of лв4.10 Mil mean?
Biovet JSC (LTS:0III) has a Other Long-Term Liabilities of лв4.10 Mil as of Dec. 2016. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Biovet JSC and its competitors.
Is Biovet JSC's Other Long-Term Liabilities too high?
Biovet JSC's current Other Long-Term Liabilities is лв4.10 Mil.
How does Biovet JSC's Other Long-Term Liabilities compare to ADMP and AGRX?
Biovet JSC's Other Long-Term Liabilities of лв4.10 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Biovet JSC and its competitors. Biovet JSC's current Other Long-Term Liabilities is лв4.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current Other Long-Term Liabilities of лв4.10 Mil. The current Other Long-Term Liabilities is лв4.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current Other Long-Term Liabilities is лв4.10 Mil as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.